⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035
globenewswire.com
NVS
PFE
AMGN
Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
AMGN
TEVA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
accessnewswire.com
VALN
PFE
What the U.S. Pharmaceutical Industry Could Learn from How Africa Solves Patient Access
accessnewswire.com
PFE
SNY
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
PFE
Pharmaceutical API Manufacturing Market Research Report 2026: $347.49 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
SNY
TEVA
Sterile Injectables CDMO Market Research Report 2026: $10.91 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
TMO
$4+ Billion OTC Dry Eye Drops Market Analysis Report 2026: Pfizer, Johnson & Johnson Services, and Novartis International Dominate
globenewswire.com
PFE
JNJ
NVS
BHC
ALC
Spring Health Named to TIME's List of the TIME100 Most Influential Companies of 2026
prnewswire.com
MSFT
PFE
BLK